Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
AZELAIC ACID
Intendis GmbH
15 Per Cent
Gel
2007-07-27
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Skinoren 15% Gel 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1g of Skinoren Gel contains 150 mg (15%) azelaic acid. Excipients: 1 mg Benzoic acid /g Gel 0.12 g Propylene glycol /g Gel For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Gel White to yellowish-white opaque gel 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS o For the relief of mild to moderate papular-pustular acne of the facial area. o For the topical treatment of papulopustular rosacea. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Skinoren 15 % Gel is intended for cutaneous use only. Skinoren Gel should be applied to the affected skin areas twice a day (in the morning and in the evening) and rubbed in gently. Approximately 0.5 g = 2.5 cm (1 inch) of gel is sufficient for the entire facial area. Before Skinoren Gel is applied, the skin should be thoroughly cleaned with plain water and dried. A mild skin- cleansing agent may be used. Occlusive dressing or wrappings should not be used, and hands should be washed after applying the gel. In the event of skin irritation (see section 4.8 Undesirable effects), the amount of gel per application should be reduced or the frequency of use of Skinoren Gel should be reduced to once a day until the irritation ceases. If required, the treatment should be temporarily interrupted for a few days. It is important to use Skinoren Gel continuously over the entire period of treatment. The duration of use of Skinoren Gel can vary from person to person and also depends on the severity of the skin disorder. Acne: In general, a distinct improvement becomes apparent after 4 weeks. To obtain optimum results, Skinoren Gel can be used over several months in accordance with the cli Read the complete document